OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies
Rachel Sacks‐Davis, Daniela K van Santen, Anders Boyd, et al.
The Lancet HIV (2024) Vol. 11, Iss. 2, pp. e106-e116
Closed Access | Times Cited: 11
Rachel Sacks‐Davis, Daniela K van Santen, Anders Boyd, et al.
The Lancet HIV (2024) Vol. 11, Iss. 2, pp. e106-e116
Closed Access | Times Cited: 11
Showing 11 citing articles:
The Natural History of Hepatitis C Virus Infection and Disease in the Era of Curative Therapy with Direct-Acting Antivirals
Maurizia Rossana Brunetto, Ferruccio Bonino
Viruses (2025) Vol. 17, Iss. 3, pp. 319-319
Open Access
Maurizia Rossana Brunetto, Ferruccio Bonino
Viruses (2025) Vol. 17, Iss. 3, pp. 319-319
Open Access
Are reinfections undermining HCV elimination efforts?
David Chromy, Mattias Mandorfer
The Lancet HIV (2024) Vol. 11, Iss. 2, pp. e68-e69
Closed Access | Times Cited: 1
David Chromy, Mattias Mandorfer
The Lancet HIV (2024) Vol. 11, Iss. 2, pp. e68-e69
Closed Access | Times Cited: 1
Annual hepatitis C testing and positive tests among gay and bisexual men in Australia from 2016 to 2022: a serial cross-sectional analysis of sentinel surveillance data
Brendan L Harney, Rachel Sacks‐Davis, Michael W. Traeger, et al.
Sexually Transmitted Infections (2024) Vol. 100, Iss. 5, pp. 295-301
Open Access | Times Cited: 1
Brendan L Harney, Rachel Sacks‐Davis, Michael W. Traeger, et al.
Sexually Transmitted Infections (2024) Vol. 100, Iss. 5, pp. 295-301
Open Access | Times Cited: 1
Loss to follow-up of patients after antiviral treatment as an additional barrier to HCV elimination
Dorota Zarębska‐Michaluk, Michał Brzdęk, Olga Tronina, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Dorota Zarębska‐Michaluk, Michał Brzdęk, Olga Tronina, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Cohort Profile: International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC)
Daniela K van Santen, Ashleigh C. Stewart, Joseph Doyle, et al.
International Journal of Epidemiology (2023) Vol. 53, Iss. 1
Open Access | Times Cited: 2
Daniela K van Santen, Ashleigh C. Stewart, Joseph Doyle, et al.
International Journal of Epidemiology (2023) Vol. 53, Iss. 1
Open Access | Times Cited: 2
The Application of Australian Rights Protections to the Use of Hepatitis C Notification Data to Engage People ‘Lost to Follow Up’
Freya Saich, Shelley Walker, Margaret Hellard, et al.
Public Health Ethics (2024) Vol. 17, Iss. 1-2, pp. 40-52
Open Access
Freya Saich, Shelley Walker, Margaret Hellard, et al.
Public Health Ethics (2024) Vol. 17, Iss. 1-2, pp. 40-52
Open Access
Hcv Reinfection in Active Drug Users from Facts to Explanations and Possible Solutions
Remy AJ, Del Monte J, Jérémy Hervet, et al.
Journal of Drugs Addiction & Therapeutics (2024), pp. 1-7
Open Access
Remy AJ, Del Monte J, Jérémy Hervet, et al.
Journal of Drugs Addiction & Therapeutics (2024), pp. 1-7
Open Access
A framework for approaching hepatitis C reinfection in people who use drugs
Rebecca G. Kim, Jennifer C. Price
Clinical Liver Disease (2024) Vol. 23, Iss. 1
Open Access
Rebecca G. Kim, Jennifer C. Price
Clinical Liver Disease (2024) Vol. 23, Iss. 1
Open Access
Analysing HCV incidence trends in people who inject drugs using serial behavioural and seroprevalence data: A modelling study
Conor Egan, Ross Harris, Holly Mitchell, et al.
International Journal of Drug Policy (2024), pp. 104469-104469
Open Access
Conor Egan, Ross Harris, Holly Mitchell, et al.
International Journal of Drug Policy (2024), pp. 104469-104469
Open Access
Hepatitis C epidemiology and treatment outcomes in Italy: Impact of the DAA era and the COVID ‐19 pandemic
Maria Paola Tramonti Fantozzi, Luca Ceccarelli, Davide Petri, et al.
Journal of Viral Hepatitis (2024) Vol. 31, Iss. 10, pp. 623-632
Open Access
Maria Paola Tramonti Fantozzi, Luca Ceccarelli, Davide Petri, et al.
Journal of Viral Hepatitis (2024) Vol. 31, Iss. 10, pp. 623-632
Open Access
Loss to follow-up of patients after antiviral treatment as an additional barrier to HCV elimination
Zarębska-Michaluk Dorota, Brzdęk Michał, Olga Tronina, et al.
(2024)
Closed Access
Zarębska-Michaluk Dorota, Brzdęk Michał, Olga Tronina, et al.
(2024)
Closed Access
